Many effective oral therapies are available to treat T2DM, including sulfonylureas, meglitinides (i.e., non-sulfonylurea insulin secretagogues), biguanides, thiazolidinediones, α-glucosidase inhibitors, and dipeptidyl peptidase-4 inhibitor [1,6]. This evidence concerns the gene INS and type 2 diabetes mellitus.